MedTrace Logo

Ileal Interposition With Sleeve Gastrectomy for Control of Diabetes

NCT00834626 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2012-09-06

Study results available
· View outcomes & findings →

Summary

Ileal interposition shifts a segment of ileum proximally to achieve maximal meal stimulated Glucagon-Like Peptide-1 secretion and coupled with a limited/complete sleeve gastrectomy (depending on the Body Mass Index), for Ghrelin reduction, helps in achieving good glycemic control in Type 2 Diabetes patients.

Conditions

Interventions

PROCEDURE

Ileal Interposition with Sleeve Gastrectomy

Transposition of a segment of Ileum proximally coupled with limited /complete sleeve gastrectomy.

Sponsors & Collaborators

  • Kirloskar Hospital

    lead OTHER

Principal Investigators

  • Dr Surendra Ugale, MS · Kirloskar Hospital, Hyderabad

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-05-31
Completion
2011-05-31

Countries

  • India

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00834626 on ClinicalTrials.gov